The total number entries retrieved from this search are 2

ID	Name	Sequence	N-Terminal Modification	C-Terminal Modification	Chemical Modification	Linear/Cyclic	Length	Chirality	Nature	Source	Origin	Species	Strain	Inhibition Concentration	In vitro/ In vivo	Cell Line	Intracellular Inhibition	Cytotoxicity	Animal Model	Effective Dose in model organism	Immune Responce	Mechanism of Action	Target	Combination Therapy	Other Activities	Year of Publication	Pubmed ID/ Patent No.
antitb_1195	Boropentapeptide	AVKAA-B(OH)2	Free	Conjugated with Boronic acid	Conjugated with Boronic acid	Linear	5	L	NA	Synthetic	NA	Mycobacterium thermoresistible	Mycobacterium thermoresistible	Poorer inhibition than Pinanediol PD-protected Boropentapeptide	In vitro	None	NA	NA	None	NA	NA	Inhibit enzyme (MycP1) reponsible for cleavage of virulence factor (ESX secretion-associated protein B (EspB))	Mycosin protease-1 (MycP1)	None	None	2014	24915878
antitb_1198	Pinanediol PD-protected Boropentapeptide	AVKAA-BO2(PD)	Free	Conjugated with Boronic acid and pinanediol PD	Conjugated with Boronic acid and pinanediol PD	Linear	5	L	NA	Synthetic	NA	Mycobacterium thermoresistible	Mycobacterium thermoresistible	IC50 = 121.6 ± 25.3 μM for MycP1	In vitro	None	NA	NA	None	NA	NA	Inhibit enzyme (MycP1) reponsible for cleavage of virulence factor (ESX secretion-associated protein B (EspB))	Mycosin protease-1 (MycP1)	None	None	2014	24915878